chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Pain, Pain in extremity, Vomiting
Clinical narrative: Felt like she was hit by a train; Sweating; Freezing cold; Couldn't eat; Threw up and had the runs; Headache; Wiped out and drained/ out of it; Weak; Achy; Started to feel foggy in her head; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), FEELING ABNORMAL (Started to feel foggy in her head), ASTHENIA (Weak), PAIN (Achy) and PAIN (Felt like she was hit by a train) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 08-Mar-2021, the patient experienced FEELING ABNORMAL (Started to feel foggy in her head). On 09-Mar-2021, the patient experienced ASTHENIA (Weak), PAIN (Achy), HEADACHE (Headache) and FATIGUE (Wiped out and drained/ out of it). On 10-Mar-2021, the patient experienced PAIN (Felt like she was hit by a train), HYPERHIDROSIS (Sweating), FEELING COLD (Freezing cold), FEEDING DISORDER (Couldn't eat) and VOMITING (Threw up and had the runs). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) at a dose of UNK dosage form and NAPROXEN SODIUM (ALEVE) at a dose of UNK dosage form. On 07-Mar-2021, PAIN IN EXTREMITY (Arm was sore) had resolved. On 09-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, FEELING ABNORMAL (Started to feel foggy in her head), PAIN (Achy), PAIN (Felt like she was hit by a train), HYPERHIDROSIS (Sweating), FEELING COLD (Freezing cold), FEEDING DISORDER (Couldn't eat), VOMITING (Threw up and had the runs) and FATIGUE (Wiped out and drained/ out of it) was resolving and ASTHENIA (Weak) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: patient has not received second dose it is past 42 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient has not received second dose it is past 42 days) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concomitant products included METFORMIN, AMLODIPINE, HYDROCHLOROTHIAZIDE, GLIMEPIRIDE, BENAZEPRIL and ATORVASTATIN for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient has not received second dose it is past 42 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient has not received second dose it is past 42 days) had resolved.            No concomitant drugs included; Reporter's Comments: Case to be considered for deletion.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Diarrhoea, Discomfort, Fatigue
Clinical narrative: felt very sick; Persistent sore throat; Constant diarrhea multiple times for four days; discomfort; weak; General malaise; Worn out; "little fever; Fatigue/ tired; terrible intense head ache; chills; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (felt very sick), OROPHARYNGEAL PAIN (Persistent sore throat), DIARRHOEA (Constant diarrhea multiple times for four days), DISCOMFORT (discomfort) and ASTHENIA (weak) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Obesity and Tachycardia. Concomitant products included WARFARIN, CHOLESTEROL, BENZOYL PEROXIDE (BP) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021 at 12:00 PM, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced HEADACHE (terrible intense head ache), CHILLS (chills) and FATIGUE (Fatigue/ tired). On 09-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Persistent sore throat), DIARRHOEA (Constant diarrhea multiple times for four days), DISCOMFORT (discomfort), ASTHENIA (weak), MALAISE (General malaise), FATIGUE (Worn out) and PYREXIA ("little fever). On an unknown date, the patient experienced ILLNESS (felt very sick). At the time of the report, ILLNESS (felt very sick), OROPHARYNGEAL PAIN (Persistent sore throat), DIARRHOEA (Constant diarrhea multiple times for four days), DISCOMFORT (discomfort), ASTHENIA (weak), MALAISE (General malaise), FATIGUE (Worn out), CHILLS (chills), PYREXIA ("little fever) and FATIGUE (Fatigue/ tired) outcome was unknown and HEADACHE (terrible intense head ache) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included patient's pharmacist suggested not to take any medication as treatment to the symptoms.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Illness, Malaise, Oropharyngeal pain, Pyrexia
Clinical narrative: felt very sick; Persistent sore throat; Constant diarrhea multiple times for four days; discomfort; weak; General malaise; Worn out; "little fever; Fatigue/ tired; terrible intense head ache; chills; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (felt very sick), OROPHARYNGEAL PAIN (Persistent sore throat), DIARRHOEA (Constant diarrhea multiple times for four days), DISCOMFORT (discomfort) and ASTHENIA (weak) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Obesity and Tachycardia. Concomitant products included WARFARIN, CHOLESTEROL, BENZOYL PEROXIDE (BP) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021 at 12:00 PM, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced HEADACHE (terrible intense head ache), CHILLS (chills) and FATIGUE (Fatigue/ tired). On 09-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Persistent sore throat), DIARRHOEA (Constant diarrhea multiple times for four days), DISCOMFORT (discomfort), ASTHENIA (weak), MALAISE (General malaise), FATIGUE (Worn out) and PYREXIA ("little fever). On an unknown date, the patient experienced ILLNESS (felt very sick). At the time of the report, ILLNESS (felt very sick), OROPHARYNGEAL PAIN (Persistent sore throat), DIARRHOEA (Constant diarrhea multiple times for four days), DISCOMFORT (discomfort), ASTHENIA (weak), MALAISE (General malaise), FATIGUE (Worn out), CHILLS (chills), PYREXIA ("little fever) and FATIGUE (Fatigue/ tired) outcome was unknown and HEADACHE (terrible intense head ache) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included patient's pharmacist suggested not to take any medication as treatment to the symptoms.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Feeling cold, Pain
Clinical narrative: feeling cold; chills were so bad that was shivering; Still feeling not 100%; Every inch of the body was aching; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Every inch of the body was aching), FEELING COLD (feeling cold), CHILLS (chills were so bad that was shivering) and FEELING ABNORMAL (Still feeling not 100%) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. A27A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN (Every inch of the body was aching). On 12-Mar-2021, the patient experienced FEELING COLD (feeling cold), CHILLS (chills were so bad that was shivering) and FEELING ABNORMAL (Still feeling not 100%). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, PAIN (Every inch of the body was aching), FEELING COLD (feeling cold), CHILLS (chills were so bad that was shivering) and FEELING ABNORMAL (Still feeling not 100%) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Patient reported that didn't had any fever and that needed an extra blanket and stated that is still feeling not 100%.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Got a 1.5 ml injection; A spontaneous report was received from a consumer concerning a 27-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced got a 1.5 ml injection/Incorrect dose administered.  The patient's medical history, was not provided by the reporter. Concomitant medications reported included warfarin, aripiprazole, folic acid, prednisone, benztropine, salbutamol (inhaler).  On 12 Mar 2021, approximately same day prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (Lot number:001B21A ) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   On 12 Mar 2021, prior to receiving mRNA-1273, the patient felt got a 1.5 ml injection .Treatment for the events was included that patient was sent home with Benadryl pill.  Action taken with mRNA-1273 in response to the events was not  applicable.   The events,got a 1.5 ml injection was considered resolved on12 Mar 2021.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273, lot # 001B21A with no associated AEs.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema
Clinical narrative: fluid in my right leg; This spontaneous case was reported by a consumer and describes the occurrence of OEDEMA (fluid in my right leg) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced OEDEMA (fluid in my right leg). At the time of the report, OEDEMA (fluid in my right leg) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported.  Treatment included Patient is drinking water and keeping her leg up.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Axillary pain, Headache, Tremor, Vomiting
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (her left armpit was on fire), TREMOR (body trembling), HEADACHE (headache), VOMITING (vomiting) and ANXIETY (she thought she was going to die and almost call an ambulance) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. unknown and unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced AXILLARY PAIN (her left armpit was on fire), TREMOR (body trembling), HEADACHE (headache), VOMITING (vomiting) and ANXIETY (she thought she was going to die and almost call an ambulance). At the time of the report, AXILLARY PAIN (her left armpit was on fire), TREMOR (body trembling), HEADACHE (headache), VOMITING (vomiting) and ANXIETY (she thought she was going to die and almost call an ambulance) outcome was unknown.            No Concomitant medications were reported. No Treatment medications were reported.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Bone swelling, Fatigue, Illness, Joint swelling, Lymphadenopathy
Clinical narrative: Swollen bone; swollen joints; Very sick condition; Swollen muscles; Body aches; Lymph nodes were swollen; Very tired; Achy muscles; This spontaneous case was reported by a consumer and describes the occurrence of BONE SWELLING (Swollen bone), JOINT SWELLING (swollen joints), ILLNESS (Very sick condition), MUSCLE SWELLING (Swollen muscles) and PAIN (Body aches) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced BONE SWELLING (Swollen bone), JOINT SWELLING (swollen joints), ILLNESS (Very sick condition), MUSCLE SWELLING (Swollen muscles), PAIN (Body aches), LYMPHADENOPATHY (Lymph nodes were swollen), FATIGUE (Very tired) and MYALGIA (Achy muscles). At the time of the report, BONE SWELLING (Swollen bone), JOINT SWELLING (swollen joints), ILLNESS (Very sick condition), MUSCLE SWELLING (Swollen muscles), PAIN (Body aches), LYMPHADENOPATHY (Lymph nodes were swollen), FATIGUE (Very tired) and MYALGIA (Achy muscles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient is taking concomitant medications.Concomitant medications  information was not provided.  Treatment information was not provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle swelling, Myalgia, Pain
Clinical narrative: Swollen bone; swollen joints; Very sick condition; Swollen muscles; Body aches; Lymph nodes were swollen; Very tired; Achy muscles; This spontaneous case was reported by a consumer and describes the occurrence of BONE SWELLING (Swollen bone), JOINT SWELLING (swollen joints), ILLNESS (Very sick condition), MUSCLE SWELLING (Swollen muscles) and PAIN (Body aches) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced BONE SWELLING (Swollen bone), JOINT SWELLING (swollen joints), ILLNESS (Very sick condition), MUSCLE SWELLING (Swollen muscles), PAIN (Body aches), LYMPHADENOPATHY (Lymph nodes were swollen), FATIGUE (Very tired) and MYALGIA (Achy muscles). At the time of the report, BONE SWELLING (Swollen bone), JOINT SWELLING (swollen joints), ILLNESS (Very sick condition), MUSCLE SWELLING (Swollen muscles), PAIN (Body aches), LYMPHADENOPATHY (Lymph nodes were swollen), FATIGUE (Very tired) and MYALGIA (Achy muscles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient is taking concomitant medications.Concomitant medications  information was not provided.  Treatment information was not provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Myalgia, Nausea, Neck pain
Clinical narrative: Neck pain; back pain; muscle ache; severe nausea; This spontaneous case was reported by a physician and describes the occurrence of NAUSEA (severe nausea), MYALGIA (muscle ache), NECK PAIN (Neck pain) and BACK PAIN (back pain) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE and PARACETAMOL (TYLENOL) for an unknown indication, SALBUTAMOL (ALBUTEROL HFA), ATORVASTATIN CALCIUM (LIPITOR), CARBAMAZEPINE (TEGRETOL), FISH OIL, GABAPENTIN, TRAMADOL, QUETIAPINE FUMARATE (SEROQUEL) and ONDANSETRON (ZOFRAN MELT).    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced NAUSEA (severe nausea). On 11-Mar-2021, the patient experienced MYALGIA (muscle ache). On an unknown date, the patient experienced NECK PAIN (Neck pain) and BACK PAIN (back pain). At the time of the report, NAUSEA (severe nausea), MYALGIA (muscle ache), NECK PAIN (Neck pain) and BACK PAIN (back pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain, Swelling face
Clinical narrative: Face swelling; whole bodyTrembling / Legs shaking; Teeth hurting; Achy / So achy even his hair aches; Itching at injection site; Constant headache; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Face swelling), TREMOR (whole bodyTrembling / Legs shaking), TOOTHACHE (Teeth hurting), PAIN (Achy / So achy even his hair aches) and VACCINATION SITE PRURITUS (Itching at injection site) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (Face swelling), TREMOR (whole bodyTrembling / Legs shaking), TOOTHACHE (Teeth hurting), PAIN (Achy / So achy even his hair aches), VACCINATION SITE PRURITUS (Itching at injection site), HEADACHE (Constant headache), NAUSEA (Nausea) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN at a dose of UNK dosage form. At the time of the report, SWELLING FACE (Face swelling), TREMOR (whole bodyTrembling / Legs shaking), TOOTHACHE (Teeth hurting), PAIN (Achy / So achy even his hair aches), VACCINATION SITE PRURITUS (Itching at injection site), HEADACHE (Constant headache), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Toothache, Tremor, Vaccination site pruritus
Clinical narrative: Face swelling; whole bodyTrembling / Legs shaking; Teeth hurting; Achy / So achy even his hair aches; Itching at injection site; Constant headache; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Face swelling), TREMOR (whole bodyTrembling / Legs shaking), TOOTHACHE (Teeth hurting), PAIN (Achy / So achy even his hair aches) and VACCINATION SITE PRURITUS (Itching at injection site) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (Face swelling), TREMOR (whole bodyTrembling / Legs shaking), TOOTHACHE (Teeth hurting), PAIN (Achy / So achy even his hair aches), VACCINATION SITE PRURITUS (Itching at injection site), HEADACHE (Constant headache), NAUSEA (Nausea) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN at a dose of UNK dosage form. At the time of the report, SWELLING FACE (Face swelling), TREMOR (whole bodyTrembling / Legs shaking), TOOTHACHE (Teeth hurting), PAIN (Achy / So achy even his hair aches), VACCINATION SITE PRURITUS (Itching at injection site), HEADACHE (Constant headache), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Pain in arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and PAIN IN EXTREMITY (Pain in arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis and Migraine headache. Concomitant products included METHOTREXATE SODIUM, SULFASALAZINE and INFLIXIMAB DYYB (INFLECTRA [INFLIXIMAB DYYB]) for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Headache). On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). At the time of the report, HEADACHE (Headache) and PAIN IN EXTREMITY (Pain in arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medication were provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-062187 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow-up information received on 05-May-2021 included no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-062187:Case for second dose
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Feeling abnormal, Palpitations
Clinical narrative: heart palpitations; she feels like a bumble bee on crack; some chest tightness; heart racing; very hipper as if she used a inhaler and steroids; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart palpitations), FEELING ABNORMAL (she feels like a bumble bee on crack), CHEST DISCOMFORT (some chest tightness), PALPITATIONS (heart racing) and FEELING ABNORMAL (very hipper as if she used a inhaler and steroids) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PALPITATIONS (heart palpitations), FEELING ABNORMAL (she feels like a bumble bee on crack), CHEST DISCOMFORT (some chest tightness), PALPITATIONS (heart racing) and FEELING ABNORMAL (very hipper as if she used a inhaler and steroids). At the time of the report, PALPITATIONS (heart palpitations), FEELING ABNORMAL (she feels like a bumble bee on crack), CHEST DISCOMFORT (some chest tightness), PALPITATIONS (heart racing) and FEELING ABNORMAL (very hipper as if she used a inhaler and steroids) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medication was reported
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: very very sick; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (very very sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (very very sick). At the time of the report, ILLNESS (very very sick) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication were provided   Reporter did not allow further contact
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 years old and got first dose; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old and got first dose) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 29A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history not provided).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old and got first dose). On 10-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old and got first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication use was not provided. Treatment information not provided.; Sender's Comments: This report refers to a case of inappropriate age at vaccine administration for mRNA-1273, lot # 29A21A  with no associated AEs
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Legs hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Legs hurt) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 104M20A) for COVID-19 vaccination.     Concomitant products included METOPROLOL, TRAMADOL, TIZANIDINE, FUROSEMIDE (LASIX M), GABAPENTIN, LATANOPROST and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (Legs hurt). The patient was treated with TRAMADOL at a dose of UNK dosage form and TIZANIDINE at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Legs hurt) had not resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Thermal burn, Vaccination site mass
Clinical narrative: Burny; Redness; Feels bumpy underneath the injection site; Quite warm; Arm soreness; Itchiness in the injection site; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), FEELING HOT (Quite warm), THERMAL BURN (Burny), ERYTHEMA (Redness) and VACCINATION SITE MASS (Feels bumpy underneath the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE, PROPRANOLOL, CLOZAPINE and ZOLPIDEM for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness) and VACCINATION SITE PRURITUS (Itchiness in the injection site). On 13-Mar-2021, the patient experienced FEELING HOT (Quite warm), ERYTHEMA (Redness) and VACCINATION SITE MASS (Feels bumpy underneath the injection site). On an unknown date, the patient experienced THERMAL BURN (Burny). At the time of the report, PAIN IN EXTREMITY (Arm soreness), FEELING HOT (Quite warm), THERMAL BURN (Burny), ERYTHEMA (Redness), VACCINATION SITE MASS (Feels bumpy underneath the injection site) and VACCINATION SITE PRURITUS (Itchiness in the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information were reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Burny; Redness; Feels bumpy underneath the injection site; Quite warm; Arm soreness; Itchiness in the injection site; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), FEELING HOT (Quite warm), THERMAL BURN (Burny), ERYTHEMA (Redness) and VACCINATION SITE MASS (Feels bumpy underneath the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE, PROPRANOLOL, CLOZAPINE and ZOLPIDEM for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness) and VACCINATION SITE PRURITUS (Itchiness in the injection site). On 13-Mar-2021, the patient experienced FEELING HOT (Quite warm), ERYTHEMA (Redness) and VACCINATION SITE MASS (Feels bumpy underneath the injection site). On an unknown date, the patient experienced THERMAL BURN (Burny). At the time of the report, PAIN IN EXTREMITY (Arm soreness), FEELING HOT (Quite warm), THERMAL BURN (Burny), ERYTHEMA (Redness), VACCINATION SITE MASS (Feels bumpy underneath the injection site) and VACCINATION SITE PRURITUS (Itchiness in the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information were reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vomiting
Clinical narrative: Swollen Arm - Near Injection Site; Vomiting; This spontaneous case was reported by a pharmacist and describes the occurrence of VOMITING (Vomiting) and VACCINATION SITE SWELLING (Swollen Arm - Near Injection Site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022A21A) for an unknown indication.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VOMITING (Vomiting) and VACCINATION SITE SWELLING (Swollen Arm - Near Injection Site). At the time of the report, VOMITING (Vomiting) and VACCINATION SITE SWELLING (Swollen Arm - Near Injection Site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator No treatment medications provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.      It was reported that the patient received 1st dose of Moderna vaccine on 11-Feb-2021.  No concomitant medication was reported.  It was not reported if the patient was received any corrective treatment for the event.  The action taken with response to the drug is not applicable.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Burning sensation, Eye swelling, Feeling hot, Lip swelling
Clinical narrative: Within minutes after vaccine felt that her whole body on fire/ hot; Felt body burning up; About to pass out; Eyes swollen; Lips swollen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING HOT (Within minutes after vaccine felt that her whole body on fire/ hot), BURNING SENSATION (Felt body burning up), PRESYNCOPE (About to pass out), EYE SWELLING (Eyes swollen) and LIP SWELLING (Lips swollen) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included Allergy (Severe allergy problems to shots.).    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced FEELING HOT (Within minutes after vaccine felt that her whole body on fire/ hot), BURNING SENSATION (Felt body burning up), PRESYNCOPE (About to pass out), EYE SWELLING (Eyes swollen) and LIP SWELLING (Lips swollen). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at a dose of every 4 hours. and PREDNISONE at a dose of 40 mg once a day. At the time of the report, FEELING HOT (Within minutes after vaccine felt that her whole body on fire/ hot), BURNING SENSATION (Felt body burning up), PRESYNCOPE (About to pass out), EYE SWELLING (Eyes swollen) and LIP SWELLING (Lips swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Blood pressure measurement: 90/60 (Inconclusive) Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  Treatment included prednisone 40 mg daily for 5 days and later prescribed a taper dose of prednisone.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Presyncope
Clinical narrative: Within minutes after vaccine felt that her whole body on fire/ hot; Felt body burning up; About to pass out; Eyes swollen; Lips swollen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING HOT (Within minutes after vaccine felt that her whole body on fire/ hot), BURNING SENSATION (Felt body burning up), PRESYNCOPE (About to pass out), EYE SWELLING (Eyes swollen) and LIP SWELLING (Lips swollen) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included Allergy (Severe allergy problems to shots.).    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced FEELING HOT (Within minutes after vaccine felt that her whole body on fire/ hot), BURNING SENSATION (Felt body burning up), PRESYNCOPE (About to pass out), EYE SWELLING (Eyes swollen) and LIP SWELLING (Lips swollen). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at a dose of every 4 hours. and PREDNISONE at a dose of 40 mg once a day. At the time of the report, FEELING HOT (Within minutes after vaccine felt that her whole body on fire/ hot), BURNING SENSATION (Felt body burning up), PRESYNCOPE (About to pass out), EYE SWELLING (Eyes swollen) and LIP SWELLING (Lips swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Blood pressure measurement: 90/60 (Inconclusive) Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  Treatment included prednisone 40 mg daily for 5 days and later prescribed a taper dose of prednisone.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site discolouration, Vaccination site erythema, Vaccination site warmth
Clinical narrative: Warm Mark - Near Injection Site; Round Mark - Near Injection Site; Red Mark - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm Mark - Near Injection Site), INJECTION SITE DISCOLOURATION (Round Mark - Near Injection Site) and VACCINATION SITE ERYTHEMA (Red Mark - Near Injection Site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031421A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm Mark - Near Injection Site), INJECTION SITE DISCOLOURATION (Round Mark - Near Injection Site) and VACCINATION SITE ERYTHEMA (Red Mark - Near Injection Site). At the time of the report, VACCINATION SITE WARMTH (Warm Mark - Near Injection Site), INJECTION SITE DISCOLOURATION (Round Mark - Near Injection Site) and VACCINATION SITE ERYTHEMA (Red Mark - Near Injection Site) outcome was unknown.            No concomitant medications were provided by the reporter.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Lymphadenopathy, Pruritus, Vaccination site mass, Vaccination site pain
Clinical narrative: Warm to touch; Itchiness; Swollen lymph nodes; Small lump, plum sized lump; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Small lump, plum sized lump), FEELING HOT (Warm to touch), PRURITUS (Itchiness), VACCINATION SITE PAIN (Pain at injection site) and LYMPHADENOPATHY (Swollen lymph nodes) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 015M20A) for COVID-19 vaccination.     The patient's past medical history included Lymphedema (cancer survivor. Had episodes of lymphedema before vaccination). Concurrent medical conditions included Allergy.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE MASS (Small lump, plum sized lump) and VACCINATION SITE PAIN (Pain at injection site). On 11-Mar-2021, the patient experienced FEELING HOT (Warm to touch), PRURITUS (Itchiness) and LYMPHADENOPATHY (Swollen lymph nodes). At the time of the report, VACCINATION SITE MASS (Small lump, plum sized lump), FEELING HOT (Warm to touch), PRURITUS (Itchiness), VACCINATION SITE PAIN (Pain at injection site) and LYMPHADENOPATHY (Swollen lymph nodes) outcome was unknown.            No concomitant medications were provided by the reporter.   Patient had a small lump on 09-Mar-2021 which became a plum sized lump on 11-Mar-2021. Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction, Blood pressure measurement, Hypoaesthesia, Paraesthesia
Clinical narrative: Has progressively gotten worse throughout the day; Numbness on left lip and under left eye; Tingling on left lip and under left eye; This spontaneous case was reported by a nurse and describes the occurrence of HYPOAESTHESIA (Numbness on left lip and under left eye), PARAESTHESIA (Tingling on left lip and under left eye) and ADVERSE REACTION (Has progressively gotten worse throughout the day) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Heart failure. Concomitant products included RIVAROXABAN (XARELTO) for Heart failure.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness on left lip and under left eye) and PARAESTHESIA (Tingling on left lip and under left eye). On an unknown date, the patient experienced ADVERSE REACTION (Has progressively gotten worse throughout the day). At the time of the report, HYPOAESTHESIA (Numbness on left lip and under left eye) and PARAESTHESIA (Tingling on left lip and under left eye) had not resolved and ADVERSE REACTION (Has progressively gotten worse throughout the day) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: (Inconclusive) Results not reported.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product include blood pressure medications (unspecified).  No treatment information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Condition aggravated
Clinical narrative: allergies have been way out of control; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (allergies have been way out of control) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONDITION AGGRAVATED (allergies have been way out of control). At the time of the report, CONDITION AGGRAVATED (allergies have been way out of control) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information were not provided. patient had allergies is of  entire life. Since patient received  first Moderna COVID shot,  allergies  of the patient have been way out of control.   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Vaccination site erythema, Vaccination site induration, Vaccination site warmth
Clinical narrative: some of vaccine dripped down arm; hot to touch; hardness,knot near injection site; redness; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (some of vaccine dripped down arm), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE INDURATION (hardness,knot near injection site) and VACCINATION SITE ERYTHEMA (redness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (some of vaccine dripped down arm), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE INDURATION (hardness,knot near injection site) and VACCINATION SITE ERYTHEMA (redness). The patient was treated with IBUPROFEN, PARACETAMOL (ADVIL DUAL ACTION) at an unspecified dose and frequency. At the time of the report, ACCIDENTAL UNDERDOSE (some of vaccine dripped down arm), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE INDURATION (hardness,knot near injection site) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown.      No concomitant medication was taken. The patient has been using ice packs to treat her symptoms.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site hot; Injection site itching; Injection site pain; Injection site swelling, raised; Injection site redness; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE SWELLING (Injection site swelling, raised) and VACCINATION SITE ERYTHEMA (Injection site redness) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Egg allergy, Allergic to cats, Allergic to dogs, Allergy to molds, Fish allergy (whitefish) and Penicillin allergy.    On 29-Mar-2021 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE SWELLING (Injection site swelling, raised) and VACCINATION SITE ERYTHEMA (Injection site redness). At the time of the report, VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE SWELLING (Injection site swelling, raised) and VACCINATION SITE ERYTHEMA (Injection site redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was using an unspecified prescribed cream on the affected area as a treatment for the events. Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Updated reporter details, patient demographics,relevant history,added three additional events and treatment medication On 02-Jul-2021: Patient's date of birth was updated